# Xponential Fitness

Type: Company (XPOF)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/xponential-fitness
Canonical HTML page: https://getbiobrief.com/entity/xponential-fitness

## Recent coverage (2 stories)

### Analyst Sentiment Diverges for Biotech Leaders Apogee and Arcturus
2026-03-19 14:56:50 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Apogee Therapeutics and Arcturus Therapeutics experienced a wave of conflicting analyst activity on Thursday, with both companies facing significant downgrades alongside new initiations. This institutional tug-of-war highlights the increasing volatility and selective nature of investment in mid-cap biotechnology firms.
Full story: https://getbiobrief.com/story/apogee-arcturus-analyst-ratings-divergence

### Viatris and CRA International Set for Q4 Earnings Amid Pharma Shifts
2026-02-25 05:12:42 · Sentiment: Neutral · Impact: 5/10 · Sources: 5

Viatris (VTRS) and CRA International (CRAI) are scheduled to report Q4 results on February 26, 2026, providing critical insights into the generic drug market and life sciences consulting demand. These reports come as the industry faces significant regulatory and pricing headwinds from the Inflation Reduction Act and a shifting biosimilar landscape.
Full story: https://getbiobrief.com/story/viatris-crai-q4-earnings-pharma-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.